|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0023981,
umls-concept:C0027051,
umls-concept:C0030705,
umls-concept:C0036980,
umls-concept:C0205225,
umls-concept:C0220825,
umls-concept:C0231242,
umls-concept:C0288672,
umls-concept:C0520886,
umls-concept:C0522523,
umls-concept:C1274040,
umls-concept:C1948041
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-7-3
|
|
pubmed:abstractText |
Patients with acute myocardial infarction complicated by cardiogenic shock have a high mortality despite the use of early reperfusion therapies with thrombolysis or percutaneous coronary intervention (PCI). Therefore, there is still need to evaluate therapy strategies in these patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1042-3931
|
|
pubmed:author |
pubmed-author:ALKK Study Group,
pubmed-author:BischoffKarl-OttoKO,
pubmed-author:HornStefanS,
pubmed-author:JakschRainerR,
pubmed-author:MarsalekParvanehP,
pubmed-author:NeuhausKarl-LudwigKL,
pubmed-author:TebbeUlrichU,
pubmed-author:ToepelWolfgangW,
pubmed-author:VohringerHans FHF,
pubmed-author:WeberMichaelM,
pubmed-author:ZeymerUweU
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
385-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12840235-Adult,
pubmed-meshheading:12840235-Aged,
pubmed-meshheading:12840235-Angioplasty, Balloon, Coronary,
pubmed-meshheading:12840235-Antibodies, Monoclonal,
pubmed-meshheading:12840235-Female,
pubmed-meshheading:12840235-Humans,
pubmed-meshheading:12840235-Immunoglobulin Fab Fragments,
pubmed-meshheading:12840235-Male,
pubmed-meshheading:12840235-Middle Aged,
pubmed-meshheading:12840235-Myocardial Infarction,
pubmed-meshheading:12840235-Platelet Aggregation Inhibitors,
pubmed-meshheading:12840235-Prospective Studies,
pubmed-meshheading:12840235-Shock, Cardiogenic,
pubmed-meshheading:12840235-Stents
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
|
|
pubmed:affiliation |
Medizinische Klinik II, Klinikum Kassel, Germany. Uwe.Zeymer@t-online.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
